8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2014 / Double-blind randomized controlled trial
Sixteen recreationally active men underwent 4 weeks of high-intensity interval training (3 days per week) while randomly assigned to receive daily resveratrol (150 mg) or placebo in a double-blind trial. A significant increase in peak aerobic power occurred in the placebo group only (p < 0.05). Both groups showed main training effects for peak oxygen uptake (placebo: 51.3 ± 1.8 to 54.5 ± 1.5 mL·kg(-1)·min(-1); resveratrol: 49.6 ± 2.2 to 52.3 ± 2.5 mL·kg(-1)·min(-1)) and Wingate peak power (placebo: 747 ± 39 to 809 ± 31 W; resveratrol: 679 ± 39 to 691 ± 43 W). Fold changes in PGC-1α, SIRT1, and SOD2 gene expression following training were significantly lower in the resveratrol group compared to placebo.
Scribbans TD, Ma JK, Edgett BA, et al. Appl Physiol Nutr Metab, 2014. PMID 25211703
2014 / Randomized crossover trial
In a randomized crossover study, 50 patients with type 2 diabetes and 50 healthy controls completed two 3-hour meal tolerance tests with a processed meat meal (M-meal) versus an isocaloric vegan meal (V-meal). The M-meal caused a greater postprandial increase in lipids in both groups (p<0.001) and persistent hyperinsulinemia in diabetes patients (p<0.001). In healthy controls, GIP, PYY, and PP concentrations were higher and ghrelin was lower after the M-meal; however, in type 2 diabetes patients, GIP, PYY, and PP were significantly lower after the M-meal (p<0.001). Additionally, the M-meal led to a larger increase in lipoperoxidation in patients with diabetes compared to the V-meal (p<0.05).
Belinova L, Kahleova H, Malinska H, et al. PLoS One, 2014. PMID 25222490
2014 / Experimental study in mice and healthy human subjects
Researchers evaluated the metabolic effects of commonly used non-caloric artificial sweeteners (NAS) in mice and healthy human subjects. NAS consumption drove the development of glucose intolerance through compositional and functional changes in the intestinal microbiota. These deleterious effects were abrogated by antibiotics and transferred to germ-free mice via fecal transplantation. Similar NAS-induced dysbiosis and glucose intolerance were demonstrated in healthy human subjects.
Suez J, Korem T, Zeevi D, et al. Nature, 2014. PMID 25231862
2014 / Randomized crossover trial
In 24 healthy adults, consuming a deep-fried Mars bar produced a non-significant reduction in cerebrovascular reactivity compared to porridge (mean difference in absolute Breath Holding Index -0.11, p=0.40). No overall difference occurred across the full sample, though a modest reduction was noted in males. A significant difference in absolute change appeared between genders (mean difference women minus men 0.65, 95% CI 0.30 to 1.00, p=0.0003).
Dunn WG, Walters MR Scott Med J, 2014. PMID 25246421
2014 / Randomized controlled trial
A randomized trial assigned 74 obese adults to alternate day fasting with fast-day meals consumed at lunch, dinner, or divided into small meals for 8 weeks. Weight decreased similarly across all cohorts (-3.5 ± 0.4 kg for lunch, -4.1 ± 0.5 kg for dinner, and -4.0 ± 0.5 kg for small meals; P < 0.001), alongside comparable decreases in fat mass and visceral fat. Only the small-meals regimen reduced systolic blood pressure (P < 0.05).
Hoddy KK, Kroeger CM, Trepanowski JF, et al. Obesity (Silver Spring), 2014. PMID 25251676
2014 / Randomized controlled trial
In a 6-month clinical trial, 100 men with benign prostatic hyperplasia were randomly assigned to receive prostafit or prazosin. Both groups improved in International Prostatic Symptom Score from baseline to 6 months, especially in group 2 with scores of 18 versus 22 (36% versus 44%), while quality of life was better in group 2 (25.5 vs 31.5; 51% vs 63%). Prostate specific antigen levels did not change significantly, and no complications occurred.
Shirvan MK, Mahboob MR, Masuminia M, et al. J Pak Med Assoc, 2014. PMID 25252490
2014 / Randomized crossover trial
Sixteen male smokers underwent three crossover sessions examining one cigarette alone, one cigarette after consuming 300 g of blueberries, or one cigarette after sugar water. Blueberries counteracted acute smoking-induced declines in reactive hyperemia index (-4.4 ± 0.8% versus -22.0 ± 1.1%, p < 0.01) and Framingham reactive hyperemia (+28.3 ± 19.2% versus -42.8 ± 20.0%, p < 0.0001). The fruit also blunted the smoking-related spike in systolic blood pressure (+8.4 ± 0.02% versus +13.1 ± 0.02%, p < 0.05), but did not modify arterial stiffness.
Del Bo' C, Porrini M, Fracassetti D, et al. Food Funct, 2014. PMID 25263326
2014 / Randomized open-label trial
A randomized open-label pilot trial evaluated 15 healthy male volunteers assigned to 1,000 mg of oral beta-glucan daily (n = 10) or control (n = 5) for 7 days. Serum beta-glucan concentrations were barely detectable in participants across all time points. Ingestion of oral beta-glucan did not affect leukocyte cytokine production or microbicidal activity.
Leentjens J, Quintin J, Gerretsen J, et al. PLoS One, 2014. PMID 25268806
2014 / Open-label clinical pilot study
An open-label pilot study evaluated the effects of consuming 4.25 g of dried apple peel powder (DAPP) daily for 12 weeks in 12 healthy subjects with moderate loss of joint range of motion and chronic pain. Consumption of DAPP for 12 weeks was associated with improved ROM, pain reduction, and a statistically significant improvement in serum antioxidant protective status. In vitro assays demonstrated that DAPP inhibited COX-2 and lipoxygenase enzymes and reduced ROS formation in inflammatory polymorphonuclear cells.
Jensen GS, Attridge VL, Benson KF, et al. J Med Food, 2014. PMID 25271471
2014 / Pilot clinical trial
In a pilot clinical trial, 40 depressive menopausal women were divided into four groups of 10 and received fluoxetine (10 mg), soybean (100 mg), sertraline (50 mg), or sertraline (50 mg) plus soybean (100 mg) for three months. All treated groups showed significant improvement compared to their pre-treatment baseline on both the Hamilton and Zung scales (p < 0.001). Comparing pre- minus post-treatment Zung scores, the sertraline plus soybean group showed a significantly higher effect than the other groups (p < 0.05). On the Hamilton scale, the combination showed significant differences versus soybean alone (p < 0.05) and sertraline alone (p < 0.05), but not versus fluoxetine.
Estrella RE, Landa AI, Lafuente JV, et al. Acta Pol Pharm, 2014. PMID 25272653
2014 / Randomised controlled trial
A randomised controlled trial evaluated the efficacy of daily self-weighing for weight loss in 183 obese adults over three months. Participants were assigned to an intervention group instructed to weigh themselves daily and record their weight (n=92) or a control group (n=91), with both groups receiving two known ineffective weight loss consultations. The intervention group lost 0.5 kg (95% CI 0.3 to 1.3 kg) more than controls, but this difference was not statistically significant. The authors concluded that instruction to weigh daily is ineffective as a weight loss intervention and found no evidence linking self-weighing frequency with greater weight loss.
Madigan CD, Jolly K, Lewis AL, et al. Int J Behav Nutr Phys Act, 2014. PMID 25301251
2014 / Randomized, controlled, open-label, 21-day trial
A randomized, controlled, open-label 21-day trial compared the macrobiotic Ma-Pi 2 diet with standard recommended diets in patients with type 2 diabetes. After adjusting for age, gender, baseline BMI, and physical activity, patients on the Ma-Pi 2 diet showed significantly greater reductions in FBG (95% CI: 1.79; 13.46), PPBG (95% CI: 5.39; 31.44), and HbA1c (95% CI: 1.28; 5.46). The Ma-Pi 2 group also had significantly greater reductions in insulin resistance, total cholesterol, LDL cholesterol, LDL/HDL ratio, BMI, body weight, and waist and hip circumference, while the control group showed a significantly greater reduction in triglycerides.
Soare A, Khazrai YM, Del Toro R, et al. Nutr Metab (Lond), 2014. PMID 25302069
2014 / Placebo-controlled, double-blind, randomized trial
In a randomized trial, 44 young men aged 13-27 with moderate to severe ASD received daily oral sulforaphane (50-150 µmol; n=29) or placebo (n=15) for 18 weeks, followed by 4 weeks without treatment. After 18 weeks, the placebo group experienced minimal change (<3.3%), while the sulforaphane group showed a 34% decline on the ABC (P < 0.001) and a 17% decline on the SRS (P = 0.017), indicating behavioral improvement. On the CGI-I, significantly more participants receiving sulforaphane showed improvement in social interaction, abnormal behavior, and verbal communication (P = 0.015-0.007). Scores on all scales returned toward pretreatment levels after treatment discontinuation.
Singh K, Connors SL, Macklin EA, et al. Proc Natl Acad Sci U S A, 2014. PMID 25313065
2014 / Randomized within-subject crossover trial
Three randomized within-subject experiments evaluated blood glucose (BG) responses to whole, puréed, and powdered pulses (navy beans in Experiment 1, lentils in Experiment 2, chickpeas in Experiment 3) versus whole-wheat flour, followed by a pizza meal at 120 minutes. Pulse forms did not predict their effect on BG response. Compared with control, navy bean treatments lowered peak BG concentrations (P < 0.05) but not 120-minute mean BG, whereas all lentil (P = 0.008) and chickpea (P = 0.002) treatments lowered mean BG over 120 minutes.
Anderson GH, Liu Y, Smith CE, et al. Br J Nutr, 2014. PMID 25327223
2014 / Clinical trial
Researchers evaluated the effects of 30-day oral administration of 100 mg/day of glucan in 60 children aged 8-12 years with chronic respiratory problems. Salivary levels of albumin, lysozyme, CRP, and calprotectin were measured. The treatment resulted in a significant increase in the production of lysozyme, CRP, and calprotectin.
Richter J, Svozil V, Král V, et al. Ann Transl Med, 2014. PMID 25332991
2014 / Two placebo-controlled crossover trials
Two human crossover trials tested blueberry anthocyanins against placebo: trial S2 (n = 72) tested two doses (271 and 7.11 mg cyanidin 3-glucoside equivalents [C3g eq]) over 3 weeks, and trial L1 (n = 59) tested 346 mg C3g eq over 12 weeks. In both trials, neither dark adaptation nor functional night vision improved. However, anthocyanins hastened visual acuity recovery after photobleaching (S2: P = 0.014 for both doses; L1: P = 0.027 at 8 weeks, P = 0.030 at 12 weeks). The authors note it is unknown whether this improvement impacts everyday vision.
Kalt W, McDonald JE, Fillmore SA, et al. J Agric Food Chem, 2014. PMID 25335781
2014 / Experimental exposure trial
Researchers examined BPA absorption when men and women held thermal receipt paper immediately after applying hand sanitizer containing dermal penetration enhancing chemicals and subsequently ate French fries. Significant free BPA transferred to participants' hands and then to the food. The combination of dermal and oral absorption led to a rapid and dramatic average maximum increase (Cmax) in unconjugated (bioactive) BPA of ~7 ng/mL in serum and ~20 µg total BPA/g creatinine in urine within 90 minutes.
Hormann AM, Vom Saal FS, Nagel SC, et al. PLoS One, 2014. PMID 25337790
2014 / Randomized crossover trial
Researchers evaluated a low-fat plant-based diet followed by an elimination diet compared to a placebo supplement in 42 adults with migraines. Worst headache pain dropped 2.1 cm on a visual analog scale on the diet versus 0.7 cm on the supplement (p=0.03). However, reductions in headache intensity (p=0.20) and weekly frequency (p=0.61) were not significantly different between the 16-week intervention periods.
Bunner AE, Agarwal U, Gonzales JF, et al. J Headache Pain, 2014. PMID 25339342
2014 / Double-blind, placebo-controlled, randomized crossover trial
Fourteen male volunteer soldiers drank 250 ml of beverages containing 80 mg caffeine, 1000 mg taurine, both, a commercial energy drink (Red Bull), or a placebo in a randomized crossover design. Following placebo ingestion, mean values were 61.3 ± 6.2 ml/kg.min for VO2max, 196 ± 6.8 bpm for maximum heart rate, 17 ± 1.2 min for time to exhaustion, 56.8 ± 6.6 kgf for right handgrip strength, 41.1 ± 3.8 cm for vertical jump, 19.9 ± 5.9 for the Grid test, and 10.9 ± 3.1 for the Digits test. Comparisons among treatments showed no statistically significant differences in any physical or cognitive performance tests, and no adverse effects were reported.
Kammerer M, Jaramillo JA, García A, et al. J Int Soc Sports Nutr, 2014. PMID 25389379
2014 / Observational study followed by a randomized controlled pilot trial
In an observational study of 258 patients with infections receiving antibiotics, 107 were offered a probiotic drink containing Lactobacillus casei DN 114001 b.i.d. AAD incidence was 6.5% in the probiotic group versus 28.4% in controls, and duration was 1.7 ± 1.1 versus 3.1 ± 2.1 days. A second randomized controlled pilot study of 60 patients directly compared two probiotic drinks and confirmed the preventive effect for L. casei DN 114001, but found no advantage for a drink containing Lactobacillus casei Shirota.
Dietrich CG, Kottmann T, Alavi M World J Gastroenterol, 2014. PMID 25400470
2014 / Randomized controlled trial
Hypertensive participants were randomly assigned to consume 35 g/day of chia flour or placebo for 12 weeks across three groups: treated with medication (CHIA-MD, n=10), untreated (CHIA-NM, n=9), and placebo (PLA-MD, n=7). Mean clinical blood pressure decreased in the combined CHIA group (111.5 ± 1.9 to 102.7 ± 1.5 mmHg, p < 0.001) and CHIA-MD (111.3 ± 2.2 to 100.1 ± 1.8 mmHg, p < 0.001), while CHIA-NM showed reduced systolic BP (146.8 ± 3.8 to 137.3 ± 3.1 mmHg, p < 0.05). All supplemented groups had a reduction in 24-hour ambulatory systolic BP, and lipid peroxidation decreased in the CHIA (p = 0.04) and CHIA-NM (p = 0.02) groups compared with placebo.
Toscano LT, da Silva CS, Toscano LT, et al. Plant Foods Hum Nutr, 2014. PMID 25403867
2014 / Inpatient simulated shiftwork intervention study
Fourteen adults were evaluated in a 6-day inpatient simulated shiftwork protocol to assess metabolic changes between day and nightshift schedules. Total daily energy expenditure increased by ~4% on the transition day to the first nightshift, but decreased by ~3% on each of the second and third nightshift days. Energy expenditure decreased by ~12-16% during scheduled daytime sleep opportunities, and the thermic effect of feeding decreased after a late dinner on the first nightshift. Hunger ratings decreased during nightshift days despite reductions in 24-hour levels of leptin and peptide-YY, while total daily fat utilization increased on the first and second nightshift days.
McHill AW, Melanson EL, Higgins J, et al. Proc Natl Acad Sci U S A, 2014. PMID 25404342
2014 / Randomized controlled trial
In a randomized trial with 16 healthy participants, partial sleep restriction to 5.1 hours nightly for 8 days significantly impaired flow-mediated dilation from 8.6±4.6% to 5.2±3.4% (P=0.01). Control sleep averaged 6.9 hours nightly and showed no change (5.0±3.0% to 6.73±2.9%, P=0.10), producing a between-group difference of -4.40% (95% CI -7.00 to -1.81%, P=0.003). Non-flow mediated vasodilation remained unchanged in both groups.
Calvin AD, Covassin N, Kremers WK, et al. J Am Heart Assoc, 2014. PMID 25424573
2014 / Randomized controlled trial
Twenty healthy young women adhering to a hypocaloric diet were randomly assigned to perform 1 hour of steady-state aerobic exercise 3 days per week for four weeks either after an overnight fast (n = 10) or after consuming a meal replacement shake (n = 10). Both groups demonstrated a significant loss of body weight (P = 0.0005) and fat mass (P = 0.02) from baseline. However, no significant between-group differences were observed in any outcome measure.
Schoenfeld BJ, Aragon AA, Wilborn CD, et al. J Int Soc Sports Nutr, 2014. PMID 25429252